2026年7月23日，高视医疗科技有限公司（02407）公告称，基于对未经审计综合管理账目的初步审阅，预计截至2026年6月30日止六个月录得净利润约人民币13.9百万元至16.7百万元，较2025年同期的约人民币35.9百万元下降约53.5%至61.3%。\n\n公告显示，公司预计2026年上半年收入约人民币5.42亿元至6.49亿元，较2025年同期的约人民币6.53亿元减少约0.7%至17.1%。收入下滑主要因为在国家政策引导下市场需求结构变化，以及海外飞白产品代理合作终止导致经销产品收入下降。\n\n同期，公司预计汇兑损失增加约人民币7.8百万元至9.8百万元，进一步影响盈利水平。\n\n高视医疗表示，相关数据仍待核数师审核，并计划于2026年8月底发布正式的中期业绩公告。公司提醒投资者在买卖公司股份时保持审慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.